Merkle Capital, a Thailand-based digital asset manager, has launched M-INJ, Asia's first regulated investment fund focused solely on Injective's native token, INJ. Approved by Thailand's Securities and Exchange Commission, the fund offers both retail and institutional investors a compliant way to gain exposure to INJ without using unregulated exchanges. This single-asset fund simplifies custody and compliance but carries market risk due to its concentrated nature. The launch aligns with Injective's growing global regulatory acceptance, including INJ futures trading in the US and pending ETF applications.
Siren (SIREN) surged 29.65% to $0.7415 following recent platform upgrades that improved its efficiency, signaling rising interest in decentralized finance. Meanwhile, LAB experienced a sharp decline of 36.95% to $10.89 due to a significant sell-off i...
Injective (INJ) overcame a prolonged downtrend by breaking the key $6.29 resistance level, signaling renewed buyer confidence after a low near $2.61. Despite a recent 5% pullback as short-term holders took profits and Bitcoin corrected, the RSI near ...
Injective has introduced the Vulcan mainnet upgrade proposal, now live for INJ stakers to vote on. This upgrade aims to improve execution efficiency, enhance on-chain modules, and refine INJ token buyback mechanics tied to network activity, potential...
Space ID (ID) token saw a sharp price increase on South Korea's Upbit exchange, rising about 7.9% to 64.2 won amid a 300% surge in trading volume, reaching roughly 209 billion won ($152 million). The token topped Upbit's 'fear and greed' index with a...
